Inato

Inato is a global clinical trial marketplace that aims to increase patient access to clinical trials worldwide. According to the vendor, this platform connects sponsors with community-based research sites, bringing clinical research to patients where they live. Inato caters to sponsors of all sizes, from small startups to large pharmaceutical companies. It is widely used by pharmaceutical companies, contract research organizations (CROs), clinical research sites, medical research institutions, and healthcare providers.

Key Features

Clinical Trial Marketplace: Inato serves as a global clinical trial marketplace, connecting sponsors with community-based research sites. According to the vendor, this platform accelerates the pace of medical innovation by increasing patient access to trials worldwide.

End-to-End Support Model: Inato provides an end-to-end support model for sponsors and research sites. The vendor claims that this model helps sponsors confidently partner with a broader range of sites around the world, ensuring reliable matching of the right sites to the right trials on a global scale.

Site Selection and Matching: Inato assists sponsors in finding and selecting the most suitable research sites for their trials. According to the vendor, qualified sites mark their interest in a trial, and Inato recommends only those that meet the sponsor's needs. This platform also supports community sites in offering more trials to their patients.

Enrollment Plan: Interested sites submit an Enrollment Plan to Inato, outlining their capabilities, experience, past performance, diversity breakdown, and patient potential. According to the vendor, this plan helps sponsors assess site fit and make well-informed decisions. Inato's team personally verifies the Enrollment Plan with sites and recommends those that align best with the trial protocol.

Accelerated Timelines: Inato's platform enables advanced pre-planning and frequent communication with sites, reducing miscommunications and delays. The vendor claims that the end-to-end support provided by the platform leads to faster timelines in trial activation, resulting in accelerated trial execution for sponsors.

Diverse Participation: Inato's platform supports sponsors in selecting sites with specific diversity capabilities and patient access to meet trial targets. Through its Inclusive Research Program, sponsors can achieve diverse participation in their trials. According to the vendor, Inato's Verified Commitment, based on site evidence, increases the accuracy and predictability of enrollment numbers.

Increased Site Engagement: Inato's comprehensive trial applications and support model drive faster response rates, reduce startup costs, and shorten timelines for research sites. The vendor states that the platform's end-to-end support ensures that sites receive guidance and assistance throughout the trial process, helping them reach their goals effectively.

Trial Publication and Visibility: Sponsors can publish the high-level details of their upcoming trials on the Inato platform. According to the vendor, this provides visibility to qualified sites worldwide, allowing them to view and express interest in trial opportunities. Inato's recommendation system ensures that trials reach the right sites, while sponsors gain access to a wide range of potential research sites.